Ray Dalio
HAE icon

Ray Dalio’s Haemonetics HAE Stock Holding History

Ray Dalio’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.73M Buy
+48,377
New +$3.15M 0.01% 585
2025
Q4 		– Sell
-59,104
Closed -$2.88M – 1112
2025
Q3 		$2.88M Buy
59,104
+12,820
+28% +$794K 0.01% 633
2025
Q2 		$3.45M Buy
46,284
+24,764
+115% +$1.64M 0.01% 369
2025
Q1 		$1.37M Buy
21,520
+16,128
+299% +$1.1M 0.01% 490
2024
Q4 		$421K Sell
5,392
-2,434
-31% -$196K ﹤0.01% 595
2024
Q3 		$629K Sell
7,826
-35,747
-82% -$2.89M ﹤0.01% 666
2024
Q2 		$3.6M Sell
43,573
-3,206
-7% -$282K 0.02% 419
2024
Q1 		$3.99M Sell
46,779
-7,960
-15% -$625K 0.02% 407
2023
Q4 		$4.68M Sell
54,739
-5,413
-9% -$468K 0.03% 374
2023
Q3 		$5.39M Buy
60,152
+4,957
+9% +$443K 0.03% 351
2023
Q2 		$4.7M Sell
55,195
-6,434
-10% -$544K 0.03% 320
2023
Q1 		$5.1M Buy
61,629
+2,102
+4% +$170K 0.03% 306
2022
Q4 		$4.68M Sell
59,527
-21,454
-26% -$1.72M 0.03% 372
2022
Q3 		$6M Sell
80,981
-64
-0.1% -$4.59K 0.03% 343
2022
Q2 		$5.28M Buy
81,045
+7,552
+10% +$447K 0.02% 470
2022
Q1 		$4.65M Buy
73,493
+17,518
+31% +$953K 0.02% 491
2021
Q4 		$2.97M Buy
55,975
+8,306
+17% +$506K 0.02% 406
2021
Q3 		$3.37M Sell
47,669
-4,236
-8% -$267K 0.02% 352
2021
Q2 		$3.46M Buy
+51,905
New +$3.67M 0.02% 400

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ray Dalio's HAE Position: Q1 2026 in Review

Ray Dalio opened a new position in Haemonetics (HAE) in Q1 2026: 48,377 shares worth $2.73M. The stake represents 0.01% of the portfolio and ranks #585 among its holdings. This is a return to the name: Ray Dalio previously reported a position in HAE as recently as Q3 2025.

Ray Dalio first reported a position in HAE in Q2 2021 and has held it in 19 quarters since. The position peaked at $6M in Q3 2022. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Ray Dalio held 48,377 shares of Haemonetics worth $2.73M as of Q1 2026.
  • Haemonetics was a new Ray Dalio position in Q1 2026.
  • Haemonetics made up 0.01% of Ray Dalio's portfolio in Q1 2026, its #585 holding.
  • Ray Dalio first reported a position in Haemonetics in Q2 2021 and has held it in 19 quarters since.
  • Ray Dalio's Haemonetics position peaked at $6M in Q3 2022.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.